FFA
NVAX icon

Farther Finance Advisors’s Novavax NVAX Stock Holding History

Farther Finance Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.8K Sell
997
-530
-35% -$4.75K ﹤0.01% 4569
2026
Q2 		$14.4K Buy
1,527
+417
+38% +$3.74K ﹤0.01% 4198
2026
Q1 		$8.9K Sell
1,110
-13,997
-93% -$127K ﹤0.01% 4186
2025
Q4 		$102K Sell
15,107
-10,414
-41% -$78.5K ﹤0.01% 2338
2025
Q3 		$221K Buy
25,521
+22,625
+781% +$176K ﹤0.01% 1553
2025
Q2 		$18.2K Buy
2,896
+1,937
+202% +$12.8K ﹤0.01% 2739
2025
Q1 		$5.75K Buy
959
+424
+79% +$3.5K ﹤0.01% 2991
2024
Q4 		$4.3K Sell
535
-100
-16% -$964 ﹤0.01% 2735
2024
Q3 		$8.02K Buy
635
+17
+3% +$220 ﹤0.01% 2454
2024
Q2 		$7.87K Sell
618
-240
-28% -$2.42K ﹤0.01% 2170
2024
Q1 		$3.99K Buy
858
+701
+446% +$3.25K ﹤0.01% 2171
2023
Q4 		$754 Buy
157
+117
+293% +$716 ﹤0.01% 2837
2023
Q3 		$290 Buy
40
+30
+300% +$240 ﹤0.01% 2392
2023
Q2 		$74 Sell
10
-2
-17% -$16 ﹤0.01% 2446
2023
Q1 		$83 Buy
12
+2
+20% +$18 ﹤0.01% 2294
2022
Q4 		$103 Buy
+10
New +$176 ﹤0.01% 2133

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Farther Finance Advisors's NVAX Position: Q3 2026 in Review

Farther Finance Advisors reduced its Novavax (NVAX) stake by 35% in Q3 2026, selling an estimated $4.75K and leaving 997 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4569.

Farther Finance Advisors first reported a position in NVAX in Q4 2022 and has held it in 16 quarters since. The position peaked at $221K in Q3 2025. 5 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.

  • Farther Finance Advisors held 997 shares of Novavax worth $10.8K as of Q3 2026.
  • Farther Finance Advisors sold 530 Novavax shares in Q3 2026, an estimated $4.75K.
  • Novavax made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4569 holding.
  • Farther Finance Advisors first reported a position in Novavax in Q4 2022 and has held it in 16 quarters since.
  • Farther Finance Advisors's Novavax position peaked at $221K in Q3 2025.
  • 5 funds tracked by Wall St. Rank held Novavax as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.